SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sees Unusually-High Trading Volume – Should You Buy?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) shares saw an uptick in trading volume on Tuesday. Approximately 248,002 shares traded hands during trading, an increase of 132% from the previous session’s volume of 107,089 shares. The stock last traded at $63.06 and had previously closed at $63.66.

SPDR S&P Pharmaceuticals ETF Stock Performance

The firm has a fifty day simple moving average of $69.20 and a 200-day simple moving average of $63.16. The firm has a market cap of $505.41 million, a price-to-earnings ratio of 14.28 and a beta of 0.61.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in XPH. Bank of America Corp DE lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 128.0% during the first quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock worth $43,918,000 after purchasing an additional 455,802 shares during the period. First Citizens Bank & Trust Co. grew its stake in SPDR S&P Pharmaceuticals ETF by 0.7% during the first quarter. First Citizens Bank & Trust Co. now owns 187,397 shares of the company’s stock worth $10,136,000 after purchasing an additional 1,393 shares during the period. Envestnet Portfolio Solutions Inc. increased its stake in shares of SPDR S&P Pharmaceuticals ETF by 5.3% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 180,521 shares of the company’s stock valued at $11,963,000 after acquiring an additional 9,042 shares in the last quarter. Private Advisor Group LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter valued at $3,017,000. Finally, Integrated Wealth Concepts LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at $3,350,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.